InnovAge Holding Corp. Depreciation
InnovAge Holding Corp. (INNV) reported Depreciation of $20.50 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-09-09
- InnovAge Holding Corp. depreciation for the quarter ending 2026-06-30 was $6.20M, a 93.75% increase year-over-year.
- InnovAge Holding Corp. depreciation for the quarter ending 2026-03-31 was $4.70M, a 9.62% decline year-over-year.
- InnovAge Holding Corp. depreciation for the quarter ending 2025-12-31 was $4.70M, a 9.62% decline year-over-year.
- InnovAge Holding Corp. depreciation for the quarter ending 2025-09-30 was $4.90M, a 5.77% decline year-over-year.
- InnovAge Holding Corp. depreciation for fiscal 2026 was $20.50M, a 9.04% increase from fiscal 2025.
- InnovAge Holding Corp. depreciation for fiscal 2025 was $18.80M, a 2.73% increase from fiscal 2024.
- InnovAge Holding Corp. depreciation for fiscal 2024 was $18.30M, a 23.65% increase from fiscal 2023.
- InnovAge Holding Corp. depreciation for fiscal 2023 was $14.80M, a 11.28% increase from fiscal 2022.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $10.90M derived: sum of 2 quarters · filed 2026-09-09 | $15.60M derived: sum of 3 quarters · filed 2026-09-09 | $20.50M 10-K · filed 2026-09-09 | |
| 2026-03-31 | $4.70M 10-Q · filed 2026-05-08 | $9.40M derived: sum of 2 quarters · filed 2026-05-08 | $14.30M 10-Q · filed 2026-05-08 | $17.50M derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-12-31 | $4.70M 10-Q · filed 2026-02-03 | $9.60M 10-Q · filed 2026-02-03 | $12.80M derived: sum of 3 quarters · filed 2026-09-09 | $18.00M derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-09-30 | $4.90M 10-Q · filed 2025-11-04 | $8.10M derived: sum of 2 quarters · filed 2026-09-09 | $13.30M derived: sum of 3 quarters · filed 2026-09-09 | $18.50M derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-06-30 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $8.40M derived: sum of 2 quarters · filed 2026-09-09 | $13.60M derived: sum of 3 quarters · filed 2026-09-09 | $18.80M 10-K · filed 2026-09-09 | |
| 2025-03-31 | $5.20M 10-Q · filed 2026-05-08 | $10.40M derived: sum of 2 quarters · filed 2026-05-08 | $15.60M 10-Q · filed 2026-05-08 | $20.80M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $5.20M 10-Q · filed 2026-02-03 | $10.40M 10-Q · filed 2026-02-03 | $15.60M derived: sum of 3 quarters · filed 2026-02-03 | $20.50M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-09-30 | $5.20M 10-Q · filed 2025-11-04 | $10.40M derived: sum of 2 quarters · filed 2025-11-04 | $15.30M derived: sum of 3 quarters · filed 2025-11-04 | $19.40M derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $10.10M derived: sum of 2 quarters · filed 2025-09-09 | $14.20M derived: sum of 3 quarters · filed 2025-09-09 | $18.30M 10-K · filed 2025-09-09 | |
| 2024-03-31 | $4.90M 10-Q · filed 2025-05-06 | $9.00M derived: sum of 2 quarters · filed 2025-05-06 | $13.10M 10-Q · filed 2025-05-06 | $18.00M derived: sum of 4 quarters · filed 2025-05-06 | |
| 2023-12-31 | $4.10M 10-Q · filed 2025-02-04 | $8.20M 10-Q · filed 2025-02-04 | $13.10M derived: sum of 3 quarters · filed 2025-02-04 | $16.90M derived: sum of 4 quarters · filed 2025-02-04 | |
| 2023-09-30 | $4.10M 10-Q · filed 2024-11-05 | $9.00M derived: sum of 2 quarters · filed 2024-11-05 | $12.80M derived: sum of 3 quarters · filed 2024-11-05 | $16.10M derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $8.70M derived: sum of 2 quarters · filed 2024-09-10 | $12.00M derived: sum of 3 quarters · filed 2024-09-10 | $14.80M 10-K · filed 2024-09-10 | |
| 2023-03-31 | $3.80M 10-Q · filed 2024-05-07 | $7.10M derived: sum of 2 quarters · filed 2024-05-07 | $9.90M 10-Q · filed 2024-05-07 | $10.30M 10-Q · filed 2023-05-09 | $13.60M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $3.30M 10-Q · filed 2024-02-06 | $6.50M 10-Q · filed 2024-02-06 | $9.80M derived: sum of 3 quarters · filed 2024-02-06 | $13.60M derived: sum of 4 quarters · filed 2024-02-06 | |
| 2022-09-30 | $3.10M 10-Q · filed 2023-11-07 | $6.50M derived: sum of 2 quarters · filed 2023-11-07 | $10.30M derived: sum of 3 quarters · filed 2023-11-07 | $13.10M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $7.20M derived: sum of 2 quarters · filed 2023-09-12 | $10.00M derived: sum of 3 quarters · filed 2023-09-12 | $13.30M 10-K · filed 2023-09-12 | |
| 2022-03-31 | $3.80M 10-Q · filed 2023-05-09 | $6.60M derived: sum of 2 quarters · filed 2023-05-09 | $9.90M 10-Q · filed 2023-05-09 | $12.50M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $2.80M 10-Q · filed 2023-02-07 | $6.10M 10-Q · filed 2023-02-07 | $8.70M derived: sum of 3 quarters · filed 2023-02-07 | $11.90M derived: sum of 4 quarters · filed 2023-02-07 | |
| 2021-09-30 | $3.10M 10-Q · filed 2022-11-08 | $5.90M derived: sum of 2 quarters · filed 2022-11-08 | $9.10M derived: sum of 3 quarters · filed 2022-11-08 | $11.90M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $6.00M derived: sum of 2 quarters · filed 2022-09-13 | $8.80M derived: sum of 3 quarters · filed 2022-09-13 | $11.60M 10-K · filed 2022-09-13 | |
| 2021-03-31 | $3.20M 10-Q · filed 2022-05-10 | $6.00M derived: sum of 2 quarters · filed 2022-05-10 | $8.80M 10-Q · filed 2022-05-10 | $11.60M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | $5.60M 10-Q · filed 2022-02-09 | $8.40M derived: sum of 3 quarters · filed 2022-02-09 | ||
| 2020-09-30 | $2.80M 10-Q · filed 2021-11-09 | $5.60M derived: sum of 2 quarters · filed 2021-11-09 | |||
| 2020-06-30 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $10.60M 10-K · filed 2021-09-23 | |||
| 2020-03-31 | $7.80M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |